CAS Registry Numbers
Elsevier and CAS recently reached agreement to increase cooperation in information exchange, which will improve their respective operations and service offerings. Under that agreement, Elsevier is providing enhanced electronic versions of its journal articles to CAS, and CAS in turn is helping Elsevier identify additional CAS Registry Numbers in certain of its databases. The CAS Registry Number® identification aspect of the agreement is being carried out periodically through an automated, first level, “machine comparison”. That method is neither comprehensive nor detailed relative to many chemical structure conventions, and so this resulting addition of Registry numbers does not represent a complete comparison of Elsevier resources with the CAS Registry, the most comprehensive substance collection. Nonetheless, we anticipate these added CAS Registry Numbers will be useful and helpful for search and identification of more Elsevier database substances. From time to time more CAS Registry Numbers will be added.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.